Quantcast

Vaccine Works In One Dose, No Longer Needs Ultra-Cold Storage

New stability data come as Israel study shows efficacy of single dose

FINANCIAL TIMES – The BioNTech/Pfizer Covid-19 vaccine no longer needs to be kept at ultra-low temperatures colder than the Antarctic winter, according to new results that will allow distribution to be dramatically expanded to doctors’ clinics, pharmacies and more remote regions.

Stability data, which the companies have submitted to the US regulator, show the shot can be kept at normal medical freezer temperatures of minus 15C to minus 25C for up to two weeks, compared with the previous required storage conditions of between minus 60C and minus 80C … 

BioNTech/Pfizer’s breakthrough vaccine was the first to win regulatory approval in the UK, US and EU last year, but the need to store and transport the shot below minus 60C has complicated the rollout, particularly in remote areas without “cold-chain” infrastructure.

DHL, one of the logistics companies involved in shipping the shot, said earlier this month that governments had failed to prepare for “last mile” delivery, beyond specialist distribution and storage centres.

The new storage requirements should ease those constraints and make the vaccine more competitive … 

...article continued below
- Advertisement -

The news came as an Israeli study, published in The Lancet on Friday, found that a single shot of the two-dose jab was 85 per cent effective in a further boost for BioNTech/Pfizer’s vaccine … 

CLICK SOURCE BELOW TO READ MORE.

OUR 5-PART SERIES ON COMMON VACCINE CONCERNS:

Part I: “Corners Were Cut In Covid Vaccine Testing”

Part II: “The Vaccine Changes Your DNA”

...article continued below
- Advertisement -

Part III: “People Are Getting Seriously Ill From Vaccines” 

Part IV: “The Vaccine Is Designed For Population Control”

Part V: “COVID Vaccines Have Tracers and Baby Parts”

 

- Advertisement -
- Advertisement -
- Advertisement -

TRENDING

- Advertisement -
- Advertisement -